New 2021 Forecasts Released
New Data(Vetted & Screened by LSI)
Apply to Present (In-Person) Apply to Present (Virtual) Confirmed Presenters BelowWe presented at the 2020 LSI event which led to a new (and previously non-existent) relationship with USVP. As a direct result, we just closed a $21.5M round led by USVP. A huge thank you to LSI for putting on this meeting and hosting an incredible platform that connects innovators with investors.
Angie Conley, CEO
Abilitech Medical
Addressing the stroke rehabilitation market with a suite of mobility devices to support and assist the arms and hands in functional tasks required for independence in daily life.
Visit website.
Per Persson, CEO
Acarix
Acoustic monitoring of coronary artery diseases of the heart. Modern tool for early and accurate CAD rule-out.
Visit website.
Jeff Levine, Founder/CEO
Advanced Scanners
Operating at the Intersection of Machine Vision and Digital Surgery, we aim to take the guesswork out of 23+ Million hospital-based procedures.
Visit website.
David Kuraguntla, CEO
Alio (fka GraftWorx)
Alio (San Francisco, CA) is an early commercial stage company who believes it is time we tap into the opportunity to revolutionize today’s tools for remote patient monitoring. The technologies in the current market are invasive, expensive, often provide inadequate data and do not deliver a positive user experience. Re-imagining what care looks like for those facing dialysis and heart failure has been done before, but the execution has failed. We understand chronic conditions do not merely require episodic care, but rather reliable and clinically accurate remote patient monitoring seamlessly integrating itself into a patient’s day to day life.
Visit website.
Albert Huang, Founder/CEO
Allotrope Medical
Enhancing surgical precision through safe electrical stimulation.
Visit website.
Lloyd Mencinger, President & CEO
Aqua Medical
Treating gastrointestinal disease with disruptive, vapor-based endoscopic ablation therapy.
Visit website.
Ken Coffey, CEO
AtriAN Medical
Long-term, non-thermal resolution of atrial fibrillation.
Visit website.
John Barrett, CEO
Auctus Surgical
Technology to treat pediatric scoliosis with non-fusion surgical system.
Visit website.
Nissan Elimelech, Founder & CEO
Augmedics
Advanced technologies aimed at revolutionizing surgical treatment. Initial product delivers augmented-reality head-mounted display for spine surgery which allows surgeons to see the patient’s anatomy through skin and tissue, as if they had "X-Ray Vision."
Visit website.
Molly Wade, Founder & CEO
Barologics
Disruptive technology to treat hypertension, heart failure and CKD through closed loop stimulation of Hering’s nerve.
Ziad Rouag, CEO
BIOMODEX
BIOMODEX uses 3D printing to create tissue-like anatomical twins from medical images. The anatomically accurate twins are designed to provide critical tactile and imaging feedback to users which, when paired with simulated blood flow stations, offers a unique and tailored end to end physician experience.
Visit website.
Ash Attia, CEO
Bionic Vision Technologies
BVT Bionic Eye System, the world’s first suprachoroidal visual implant, to restore functional vision to the blind suffering from inherited retinal diseases.
Visit website.
Kevin Rocco, CEO
Biorez
Biorez is developing bio-inductive implants for the $7B sports medicine market that help restore joint stability and help direct the healing and regeneration of new functional tissue. After the healing process is complete, our implants are naturally broken down by the body, restoring the anatomy without the chronic risks of permanent synthetic materials.
Visit website.
Peter Bloch, CEO
BresoTEC
Innovative devices using proprietary acoustic and accelerometer technology to diagnose sleep apnea.
Visit website.
Carol Burns, President & CEO, Co-Founder
Cagent Vascular
Treating atherosclerotic disease with the first and only serration balloon technology to restore blood flow.
Visit website.
Kristie Burns, Chief Marketing Officer
Cala Health
A bioelectronic medicine company transforming the standard of care for chronic disease.
Visit website.
Brian Hutchison, Executive Chairman and CEO
Catalyst OrthoScience
Catalyst OrthoScience develops and markets surgical implants that make orthopedic surgery less invasive and more efficient for both surgeons and patients. The company's first offering, the Catalyst CSR Total Shoulder System, represents the next evolution in total shoulder arthroplasty.
Visit website.
Philip Rackliffe, CEO
Centerline Biomedical
A Cleveland Clinic spinoff company commercializing the Intra-Operative Positioning System (IOPS™) technology — an innovative, non-x-ray based 3D GPS-like surgical navigation technology that improves endovascular procedure outcomes and reduces radiation exposure.
Visit website.
Randy Preston, Chief Business Officer
Centese
Transforming surgical drainage with intelligent digital devices to reduce complications and costs.
Visit website.
Steve Murray, CEO
Centinel Spine
Addressing spinal disease anteriorly with the widest breadth & depth of technology platforms.
Visit website.
Bradley Paddock, President & CEO
CeQur
CeQur is commercializing advanced, simple-to-use insulin delivery devices that make it easier for people living with diabetes to adhere to therapy and stay in control of their disease. The Company’s simple, three-day, wearable devices provide freedom from multiple daily insulin injections.
Visit website.
Mohan Frick, CEO
ChemoTech
The company is dedicated to innovation in cancer care and recently launched IQwave. This technology performs electrochemotherapy which is approved for the treatment of a wide range of tumors.
Visit website.
Jeffrey Weisberg, CEO
ChipCare
Multiplexed point-of-care diagnostics for sexually transmitted infections. Utilizing a patented approach for analyte detection, the platform can perform multiple classes of assays including cell surface markers, proteins and nucleic acids from an easily collected sample such as urine.
Visit website.
Don Wright, President & CEO
Clarigent Health
Helping save lives with enhanced listening. Patented AI identifies vocal biomarkers that signal potential suicidal risk, supporting clinical decisions and workflow efficiency.
Visit website.
Aly Elbadry, CEO
CloudCath
Remote monitoring platform for catheter-based treatments. CloudCath’s first served population is End Stage Renal Disease (ESRD) patients that are on Peritoneal Dialysis (PD).
Visit website.
William Altman, CEO
CorInnova
Minimally invasive, soft robotic cardiac device creating a new paradigm for heart failure treatment.
Visit website.
Lucy O'Keeffe, CEO
CroiValve
CroíValve has developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
Visit website.
Kerry Pope, CEO
Crystalline Medical
Forward-viewing, image-guided interventional system that seeks to significantly improve both the safety and efficacy of millions of procedures per year in the areas of cardiology, interventional radiology, interventional oncology, and emergency medicine.
Visit website.
Jong Lee, CEO & Cofounder
Day Zero Diagnostics
Day Zero Diagnostics uses whole genome sequencing and machine learning to modernize infectious disease diagnosis and treatment. DZD is developing a rapid diagnostic for sepsis that uses genomic data to identify a pathogen and to comprehensively profile its antibiotic resistance, as well as services for hospital infection control. Our goal is modernize hospital microbiology using NGS and a big-data approach.
Visit website.
Bill Perry, CEO
Deep Blue Medical Advances
Surgeon-invented T-Line® Hernia Mesh with integral suture-like extensions designed to eliminate a key point of failure for conventional mesh fixation - the mesh, suture, tissue interface - and to provide superior anchor strength. Additional products in development include an anchor clip for even faster, easier implantation; a biosynthetic version of the T-Line Hernia Mesh; and a coated composite version of the T-Line Mesh.
Visit website.
Cody Simmons, CEO
DermaSensor
DermaSensor, Inc. enables all medical professionals to effectively check for skin cancer. The DermaSensor device is an affordable handheld tool that uses artificial intelligence and spectroscopy to evaluate skin lesions for cancer in a matter of seconds.
Visit website.
Osman Khawar, CEO
Diality
Smart, flexible, portable, home hemodialysis machine that will enable patients to treat themselves wherever they are.
Visit website.
John Ashley, CEO
DurVena
Treatment for saphenous vein grafts that strengthens the graft and reduces the intimal hyperplasia that leads to graft failure. This treatment address three large unmet clinical markets, CABG, PAD, and AVF.
Ted Bird, Chief Strategy Officer
Dymicron
Dymicron is an innovation-driven medical technology company that is advancing a new generation of musculoskeletal devices made from Polycrystalline Diamond (PCD)—one of the strongest substances known to man, and a material for which Dymicron has exclusive patented use in all human interbody applications.
Visit website.
Claude Cohen-Bacrie, Founder, President & CEO
e-Scopics
e-Scopics is a French startup which democratizes ultrasound imaging to all healthcare professionals. It manufactures a digital transducer and a connected software APP to provides quantitative imaging for several medical conditions. The image formation process is no longer HW based but rather a SaaS running on a cell phone, a Tablet or the Cloud, with AI based algorithms for quantitative diagnosis.
Visit website.
John McCutcheon, CEO
EBR Systems
Superior treatment for millions of patients suffering from cardiac rhythm diseases by developing safe, clinically superior, cost-effective and reliable therapies using wireless cardiac stimulation.
Visit website.
Keith Carlton, CEO
EBT Medical
Disruptive neuromodulation technologies focused on pelvic floor disorders.
Visit website.
Christopher Wilson, CEO
EDGe Surgical
Single-use electronic depth gauge with superior measurement capabilities, optimized hook design and easy-to-read digital display that aims to improve accuracy, precision, and speed of these measurements while eliminating the risk of infection associated with reusable devices in orthopedic surgical procedures.
Visit website.
Ashok Khandkar, CEO
Elute
A new class of polymer-controlled drug delivery devices designed to prevent and treat orthopedic and other surgical bone infections.
Visit website.
Jeff Conroy, Co-Founder & CEO
Embody
Collagen-based implants for the treatment of tendon and ligament injuries.
Visit website.
Jim Kasic, CEO
EndoShape
Minimally invasive medical devices for peripheral vascular and neuro vascular uses in the interventional radiology market that will substantially replace existing technology.
Visit website.
Gabriel Sanchez, CEO
Enspectra Health
Enspectra Health (formerly Zebra Medical Technologies) is developing a novel system to image live cellular anatomy without cuts or stains. We aim to transform patient care across multiple conditions, beginning with the detection and treatment of skin cancers.
Visit website.
Claude Nogard, CEO
Ergosuture
Surgical solutions that help improve suturing safety, speed and versatility.
Visit website.
Marinela Gombosev, CEO, President
Evoke Neuroscience
The eVox System is a medical device that measures brain health to aid doctors in the diagnosis of cognitive disorders.
Visit website.
Jennifer Fried, CEO
ExplORer Surgical
A data-driven approach to managing and improving the most complex surgical procedures.
Visit website.
Jay Cormier, President & CEO
Eyedaptic
Visual aid software, enabled by augmented reality hardware, for macular degeneration and other retinal diseases. The software goes beyond magnification to enable a fuller field of vision, and simulates natural vision for those suffering from central vision disorders such as AMD (age-related macular degeneration), to revitalize their quality of life.
Visit website.
Joseph Muldoon, CEO
FAST BioMedical
A medical technology company focused on the development of a patented technology for measuring plasma volume and kidney function.
Visit website.
Matthieu De Beule, CEO
FEops
Predictive, personalized computational modeling and simulation solutions for structural heart interventions that empower medical device manufacturers to bring superior products faster to the market and enable physicians to improve clinical outcomes.
Visit website.
Arnaud Mascarell, CEO
FineHeart
Implantable Cardiac Output Management System (ICOMS) is a novel, wirelessly powered, fully implantable mechanical circulatory support device that is able to optimize cardiac output while preserving the heart’s innate contractility.
Visit website.
Tej M. Singh, MD, CEO
Fist Assist
Wearable device for vein identification and enhancement for the ESRD patient.
Visit website.
Matt Kesinger, CEO
Forest Devices
ALPHASTROKE is a device to help first responders identify stroke and triage patients to the right hospital.
Visit website.
Bruce Lichorowic, President & CEO
Galen Robotics
Digital-Surgery-as-a-Service (DSaaS) combining the power of a new microsurgery platform with a system of big data analytics and machine learning to provide advanced surgical assistance in performing delicate or intricate procedures.
Visit website.
Matt Miller, Director Of Technology Development
Genesis Software Innovations
Genesis Software Innovations, GSI, was formed to develop innovative and integrated software tools focused around orthopedic surgical centers.
Visit website.
Vadim Gurevich, CEO
GLW Medical Innovation
GLW Medical Innovation (“GLW”) focuses on developing innovative start-up companies, with cost-effective implant and instrument solutions in various segments of the orthopedic market. We develop technologies that improve patient outcomes and reduce the cost of implants for the healthcare industry. We partner with a select global network of surgeon pioneers and thought leaders who help GLW develop small focused companies. We commercialize products through exclusive sales distribution relationships.
Visit website.
Lorenzo Pradella, CEO
GreenBone Ortho
Bone regenerating, load-bearing implants to treat severe fractures and conditions such as trauma and tumors that result in extensive bone loss
Visit website.
Douglas Snell, Program Director
HAPPE Spine
Hydroxyapatite Porous PEEK (HAPPE) fabricated through proprietary technology to provide optimal mechanical properties of PEEK polymer materials, while providing improved surface texture inviting boney engagement, interconnected porosity for long term fixation, and the bioactive properties of HA to provide an effective construct for bone ingrowth. The HA further improves mechanical properties compared to standard PEEK, and all together, optimizes imaging for post operative diagnosis.
Visit website.
Jerry Mezger, President & CEO
Harbor MedTech
A fully integrated, commercial-stage regenerative medicine company. Two FDA-cleared and CE marked products and a broad pipeline that leverage a patented BriDGE® technology. The BriDGE® Process transforms standard type-1 collagen into a bio-friendly, stabilized collagen matrix which acts as a trigger to activate the patient’s own healing cascade.
Visit website.
John VeLure, President & CEO
i-Lumen Scientific
A novel surface neurostimulation technology (called Neural Retinal Therapy™) to restore vision in those afflicted with Dry, Age-related Macular Degeneration (or Dry AMD).
Visit website.
Amir Jafri, CEO
Immunicom
Redefining the limits of immunotherapy through the development of innovative, non-pharmaceutical treatment approaches for cancer, inflammatory diseases, and autoimmune diseases.
Visit website.
Dr Arnaud Rosier, Founder & CEO
Implicity
Remote monitoring platform for patients with connected pacemakers and defibrillators.
Visit website.
Harlee Sorkin, CEO
InterShunt Technologies
Proprietary catheter system that allows for the capture and excision of tissue from the interatrial septum. The result is a left to right atrial shunt that off-loads elevated left atrial pressure, reducing symptoms in Heart Failure patients. The mechanical system is designed for safety and ease of use and is the only interatrial shunting device that requires no implant and no energy.
Visit website.
Moufeed Kaddoura, CEO
Kenota Health
Bringing advanced testing technologies to the field of medicine, revolutionizing the way physicians test for and treat diseases.
Visit website.
Angus McLachlan, CEO
Liberate Medical
The VentFree Respiratory Muscle Stimulator uses proprietary non-invasive neuromuscular electrical stimulation to contract the abdominal wall muscles in synchrony with exhalation during mechanical ventilation.
Visit website.
Clark Tedford, President & CEO
LumiThera
Developing photobiomodulation treatments for ocular diseases and disorders.
Visit website.
Dr. Ben Lipps, CEO and Chairman
Magforce
Nanotechnology-based therapy for the treatment of cancer.
Visit website.
Manny Villafaña, PhD, Sc, Founder of St. Jude Medical, ATS, Cardiac Pacemakers
Medical 21
Developing an artificial artery to eliminate the harvesting of vessels from the patient during bypass CABG surgery.
Visit website.
Dan Myers, CEO
MediPrint Ophthalmics
Harnessing the power of the MediPrint™ process to print drug layers on FDA-approved contact lenses, MediPrint™ Ophthalmics uses its proprietary technology to develop contact lenses that provide sustained drug delivery of medications for ocular disease.
Visit website.
Thomas Dietiker, CEO
Medtor
Technology to transform accuracy in vital-sign monitoring and wearable devices with a patented spectral white light sensor. Designed for clinical grade mobile, the vital sign monitoring clears the way for broader applications.
Visit website.
Martin Stenfeldt, CEO
MedTrace Pharma
MedTrace Pharma A/S is a development stage company aiming to innovate PET diagnostic imaging by transforming blood flow quantification.
Visit website.
Michael Whitman, CEO
Micro Interventional Devices
Micro Interventional Devices, Inc. (MID), a Delawarecorporation founded in 2010, is a development stage medical device companyfocusing on the design, manufacture and commercialization of disruptivetechnologies for use in percutaneous structural heart repair procedures. MID is currently enrolling patients in a CE Mark study in Europe.
Visit website.
Mark Toland, CEO
MMI
Enhancing surgical performance through a robotic system that enables surgeons to achieve better outcomes in microsurgery. The Symani Surgical System combines proprietary innovations including the world’s smallest wristed micro instruments as well as tremor reducing and motion scaling technologies.
Visit website.
David Cuccia, Founder, CTO
Modulim
Optical imaging solutions powered by spatial frequency domain imaging that help clinicians assess compromised circulation.
Visit website.
Timothy P. Moran, CEO
Motus GI
Innovative solutions to address unmet needs in GI endoscopy, cost-effectively improving clinical outcomes that benefit patients, providers and payers worldwide.
Visit website.
Benjamin Holmes, CEO
Nanochon
Nanochon is applying novel materials to replicate bone and cartilage, and high-end 3-D printing to create an implant which can permanently repair debilitating joint injuries. The implant can bear loads like a traditional joint implant, quickly restoring a patient’s movement.
Visit website.
Alan Lucas, CEO & Founder
Navigation Sciences
Developing Image-guided Video Assisted Thoracoscopic Surgery (iVATS) technology for minimally invasive identification and removal of early stage lung tumors and other soft tissue cancers.
Visit website.
Nikhil Shah, CEO & Co-Founder
Nephrodite
Developing and commercializing our fully implantable continuous dialysis device - The Holly.
Visit website.
Joseph Connell, Chairman
NeuEsse
Plant-based human skin substitute in either a protein material bandage or a "no-touch" application protocol device (especially for burns) that is lightweight, portable, military-grade and available at any point of injury to deliver skin substitutes along with other therapeutics for military and civilian patients.
Visit website.
Bob Radie, Chairman & CEO
Neuraptive Therapeutics
Therapeutics product designed for administration during surgery to improve outcomes for patients impacted by acute nerve injury repairs and reconstructive surgical procedures involving peripheral nerves. Also developing a suite of advanced microsurgical instruments for use in peripheral nerve surgery.
Visit website.
Thomas Marchand, CEO
NIDO
NIDO (Boston, MA) is a medical device company developing SEPIA, an innovative solution for epicardial VT ablation that has been initiated by two investigators at Boston Children’s Hospital and Harvard Medical School. SEPIA will allow safe access and real-time visualization of the epicardial surface. Ultimately it will reduce complications and improve ablation efficiency, leading to decrease recurrence of VT.
Visit website.
Stephen Merrick, CEO
NorthStar Medical
Nuclear medicine technology company committed to providing stable, domestic and environmentally friendly radioisotope supply solutions to meet the needs of patients and advance clinical research. Fundamentally transforming the ways that medical radioisotopes are produced and distributed around the world.
Visit website.
Stuart Mitchell, PhD, Founder & CEO
Novuson
Novuson’s patented DTU technology will represent the first substantive innovation in over 25 years for targeting vessel sealing / dividing, and hemostasis (bleeding control) in surgical and trauma applications.
Visit website.
William Curtis, CEO
nRichDX
An emerging leader in the liquid biopsy sample prep market, delivering to downstream molecular testing up to 75X more target material (ctDNA, CTCs, exosomes, etc.) than existing sample prep systems.
Visit website.
Cristian Atria, Founder & CEO
nView Medical
3D imaging in surgery using AI image creation algorithms that merge prior information with real-time data gathered during surgery to reduce imaging time and to minimize x-ray radiation.
Visit website.
Christopher Kent, President & CEO
ODS Medical
AI-enabled optical detecion systems for tumor margin assessments.
Visit website.
Andrew McDaid, Founder & CEO
OPUM Technologies
Automated care platform for knee health. OPUM’s intelligent platform utilizes AI to provide actionable data and insights help you to manage recovery and long-term knee health.
Visit website.
Claude LeDuc, CEO
Ortho Regenerative Technologies
Orthobiologics company developing novel therapeutic tissue repair device/drug/biologic combination products to dramatically improve the success rate of Orthopedic and Sports Medicine Surgeries.
Visit website.
Lishan Aklog, MD, Chairman & CEO
PAVmed
PAVmed’s current pipeline consists of six lead products focused on medical infusion, hand surgery, pediatric ear infections, and tissue ablation. PAVmed is building it's product pipeline and has new innovations which will be announced at the Summit.
Visit website.
Kareen Looi, CEO
Pedra Technology
Non-invasive, deep tissue, real-time tissue perfusion monitor for use in peripheral angioplasty and vascular surgery.
Visit website.
Wayne Allen, CEO
Perfuze
Innovative catheter technology to treat acute ischemic stroke
Visit website.
Reinhard Krickl, CEO
Phagenesis
Transforming the lives of people with dysphagia, using revolutionary treatments developed through a commitment to scientific and clinical excellence.
Visit website.
Ryan Shelton, PhD, CEO & Co-Founder
PhotoniCare
The TOMi™ Scope uses an advanced light-based technology to see through the eardrum to fundamentally transform the diagnosis and treatment of middle ear infection.
Visit website.
Don Stewart, CEO
PlantForm
Focused on the rapid development and production of specialty antibody and protein drugs using our proprietary vivoXPRESS® platform. The plant-based vivoXPRESS® system makes it easier, faster and less expensive to produce approved biologic drugs for novel indications and new markets.
Visit website.
Angela Liedler, Chairman and CEO
Precisis
Neurostimulation for cortical functional impairments.
Visit website.
Bryan Lord, CEO
Pristine Surgical
Pristine Surgical makes a high definition single-use visualization system for minimally invasive surgery and delivers its visualization devices in complete single-use kits. The devices utilize a low-cost image processing unit which also serves as a portal to cloud-based software supporting the entire surgical episode.
Visit website.
Amit Vohra, PhD, CEO
Promaxo
Next generation office-based modular MRI and MRI based technologies. Initial focus on advancing the solutions for prostate disease management and other urology and pelvic conditions.
Visit website.
Nadine Haram, Founder & CEO
Proximie
A secure, complete software solution which expands surgical collaboration enabling surgeons to share expertise using augmented reality tools before, during and after surgery.
Visit website.
John Klock, CEO
QT Ultrasound
QT Ultrasound is a privately held technology company engaged in the research, development and commercialization of an innovative automated breast imaging system producing high-resolution transmission ultrasound images.
Visit website.
Laurence Marsteller, CEO
Radiance Therapeutics
Next-generation beta ophthalmic applicator.
Visit website.
Laura Piccinini, CEO
Respiratory Motion
Global leader in innovative Minute Ventilation Monitoring, useful across a wide variety of patient populations and environments to assess respiratory function and provide early warning of respiratory collapse.
Visit website.
Richard Hanbury, CEO
Sana Health
Non-invasive bio-therapeutic device for pain management.
Visit website.
Kevin Richardson, Chairman & CEO
SANUWAVE
A shockwave technology company developing patented, noninvasive devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures.
Visit website.
Geoffrey Klass, CEO
Sense Diagnostics
The Sense devices is a non-invasive, disposable technology that continuously monitors brain activity primarily in the intensive care unit.
Visit website.
Rob Ball, CEO
Shoulder Innovations
Total shoulder replacement system that addresses the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant.
Visit website.
Peter Boyd, CEO
Sonnest
Developing a voltage-activated, ultrasound imaging agent that will allow clinicians to assess and monitor myocardial perfusion of the heart at the bedside, in real-time using traditional ultrasound techniques.
Tom Kottler, CEO
Sonopor
A simple, novel way to treat untreatable or otherwise difficult to treat infections with its UD2™️ Ultrasonic Drug Delivery Platform, combining a proprietary ultrasound system with subcutaneous, local delivery of existing antibiotics, creating new anti-infective treatments with therapeutic advantages and minimal side effects.
Visit website.
Daniel Powell, CEO
Spark Biomedical
Transcutaneous Auricular Neurostimulation (tAN™) for opioid withdrawal relief.
Visit website.
Dushyanth Surakanti, CEO
Sparta Biopharma
The first osseointegrative biomimetic knee cartilage implant.
Visit website.
Todd Moseley, CEO
Spinal Simplicity
Innovative, simple solutions for complex spinal problems.
Visit website.
Nick Delmonico, President & CEO
Strados Labs
User-friendly sensors, unique collection methodologies, and data processing software that creates a more holistic view of a patient's respiratory health.
Visit website.
Doug Daniels, CEO
Stroma Medical
STRŌMA® is the leader in permanent eye color change, with its revolutionary STRŌMA® Laser System. Its patented laser initiates a natural metabolic process that gradually eliminates the superficial pigment in darker eyes to reveal your natural underlying color.
Visit website.
Mike Teodorescu, CEO
SurgiBox
SurgiBox is an ultraportable sterile field that fits in a backpack.
Visit website.
Wayne Markman, CEO
SYMBYX
SYMBYX is the first company in the world to trial and demonstrate success in managing Parkinson’s disease and Fibromyalgia symptoms in humans with non-pharmaceutical therapies. SYMBYX is developing light therapies, using both laser and LED light, to modify microbial colonies in the gut and mouth in order to reduce inflammation and metabolise dopamine and serotonin - two critically deficient neuro-chemicals in most people with Parkinson’s (PWP). SYMBYX therapies have recently achieved CE Marking and TGA (Australia) approval and we will be targeting FDA approval next. Various metabolic diseases, including Irritable Bowel, are a probable next focus as well Autism Spectrum Disorder (ASD, all of which have significant gut-brain linkages.
Visit website.
Attila Borbath, CEO
Synergia Medical
Leveraging photonics to create a platform for small, safe and long-lasting neurostimulators.
Visit website.
Josh Butters, CEO
Synergy Disc Replacement
The first artificial disc that has been designed to restore physiological motion and correct sagittal balance.
Visit website.
Anand Sheel, CEO
Terapede Systems
Ultra-high resolution medical flat panel X-ray detector with a 40% lower dose.
Visit website.
Alan Sage, CEO
Vaporox
Improving lives by healing wounds and saving limbs, Vaporox was formed to commercialize Vaporous HyperoxiaTherapy(VHT™). VHT is a patented and FDA-510K-cleared technology that represents a breakthrough in treating 7 different types of skin wounds, including diabetic foot ulcers (DFUs) and pressure ulcers (bedsores).
Visit website.
Ali Bakhshinejad, CEO
VasoGnosis
An Artificial Intelligence Powered diagnostic and surgical planning Software as a Service for cerebrovascular diseases.
Visit website.
Tim Boire, CEO
VenoStent
Developing bioengineered smart polymers to transform vascular surgery.
Visit website.
Adam Sachs, CEO
Vicarious Surgical
Transforming surgery through robotics and virtual reality.
Visit website.
Susan Wood, President & CEO
VIDA
VIDA is transforming lung care through intelligence, using imaging-based AI to uniquely profile and manage the patient with or at-risk of respiratory diseases.
Visit website.
John Murphy, CEO
Virtual Incision
The company is developing the MIRA® (Miniaturized In vivo Robotic Assistant) Platform, a first-of-its-kind miniaturized surgical robotic support device, focusing first on colon resection, with follow-on specialty robots for additional potential applications.
Visit website.
Peter Van Haur, CEO
VitalConnect
Reimagining a world with predictive health at our fingertips.
Visit website.
Brian Thornes, CEO
X-Bolt Trauma
Innovative devices for hip fixation and long bone nailing.
Visit website.
John Zak, President & CEO
XaTek
As a platform technology, the ClotChip™ device from XaTek is a handheld, point-of-care global assay to evaluate the hemostatic process. The ClotChip is agnostic to the cause of any defect of coagulation and is therefore uniquely situated to serve urgent needs of a number of different clinical markets.
Visit website.
John Barrett, CEO
ZKR Orthopedics
New procedure to mimic the clinical effects of tibial osteotomy procedures. Implants will be delivered to the proximal tibia below the patellar tendon, offloading and re-directing the tendon to reduce pain and inflammation.
Visit website.
